Novo Nordisk: Investors Focusing On CagriSema Results Are Missing The Big Picture
Novo Nordisk(US:NVO) Seeking Alpha·2026-02-24 14:00分组1 - Novo Nordisk A/S announced results from its latest phase 3 trial for CagriSema on February 23rd [1] - The company is listed in its home market as NOVO-B.CO [1] 分组2 - The article does not provide additional relevant content regarding the company or industry [2][3]